Full text
PDFPage 640
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Courtney M. G., Nunes D. P., Bergin C. F., O'Driscoll M., Trimble V., Keeling P. W., Weir D. G. Randomised comparison of olsalazine and mesalazine in prevention of relapses in ulcerative colitis. Lancet. 1992 May 23;339(8804):1279–1281. doi: 10.1016/0140-6736(92)91601-4. [DOI] [PubMed] [Google Scholar]
- Gait J. E., Simerl N. A. Comparisons of olsalazine and mesalazine in prevention of relapse in ulcerative colitis. Lancet. 1992 Aug 22;340(8817):486–487. doi: 10.1016/0140-6736(92)91809-m. [DOI] [PubMed] [Google Scholar]
- Record C. O., Macrae K. Mesalazine versus olsalazine for prophylaxis of ulcerative colitis relapse. Lancet. 1992 Dec 12;340(8833):1468–1468. doi: 10.1016/0140-6736(92)92656-z. [DOI] [PubMed] [Google Scholar]
- Sninsky C. A., Cort D. H., Shanahan F., Powers B. J., Sessions J. T., Pruitt R. E., Jacobs W. H., Lo S. K., Targan S. R., Cerda J. J. Oral mesalamine (Asacol) for mildly to moderately active ulcerative colitis. A multicenter study. Ann Intern Med. 1991 Sep 1;115(5):350–355. doi: 10.7326/0003-4819-115-5-350. [DOI] [PubMed] [Google Scholar]
- Sutherland L. R., May G. R., Shaffer E. A. Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis. Ann Intern Med. 1993 Apr 1;118(7):540–549. doi: 10.7326/0003-4819-118-7-199304010-00009. [DOI] [PubMed] [Google Scholar]